» Articles » PMID: 25103467

A National Survey on Availability, Price and Affordability of Selected Essential Medicines for Non Communicable Diseases in Sri Lanka

Overview
Publisher Biomed Central
Specialty Public Health
Date 2014 Aug 9
PMID 25103467
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Access to medicines is a universal right. Low availability and low affordability of medicines are issues that deny this right to a significant proportion of the world population. The objective of this study was to determine the availability, price and affordability of essential medicines prescribed to treat non communicable diseases in Sri Lanka.

Methods: Methodology was based on the 2nd edition of the World Health Organization Health Action International Manual. A country survey was conducted and facilities representing both public and private pharmacies were selected. A total of 109 facilities was surveyed. At each facility data on the availability and prices of 50 essential medicines for non communicable diseases were collected. Percentage availability, median price of originator brand and lowest priced generic, median price ratio to the International Reference Price were calculated for surveyed medicines. Affordability was determined using the daily incomes of the lowest--paid unskilled government worker.

Results: Semi government community pharmacies had the highest (>80%) availability while outdoor pharmacies of public health care facilities, private pharmacies and outdoor pharmacies of private hospital showed a fairly high availability (50 - 80%) of surveyed medicines.Unit price of 76% of selected individual medicines was less than ten Sri Lankan rupees. Out of these 28% of medicines cost less than one Sri Lanka rupee. For 21 of the surveyed medicines the median price ratio to the international reference price was less than one. The prices of originator brands for 14 surveyed medicines were more than five times that of the lowest price generics.Less than a single day's wages was adequate to purchase a month's supply of the lowest priced generic of more than 67% of surveyed medicines.

Conclusions: The availability of selected essential medicines was fairly high in both public and private sectors in Sri Lanka. Most medicines are affordable to the lowest income earners in the community. There were many generic brands and generics available for most of the medicines in private and semi government community pharmacies increasing both availability and affordability.

Citing Articles

Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.

Tajik A, Varmaghani M, Ghavami V, Saeedi N, Sharifi F, Khajavi A J Diabetes Metab Disord. 2024; 23(2):1929-1940.

PMID: 39610474 PMC: 11599510. DOI: 10.1007/s40200-024-01444-0.


A comparative systematic review of risk factors, prevalence, and challenges contributing to non-communicable diseases in South Asia, Africa, and Caribbeans.

Bhuiyan M, Galdes N, Cuschieri S, Hu P J Health Popul Nutr. 2024; 43(1):140.

PMID: 39252085 PMC: 11386079. DOI: 10.1186/s41043-024-00607-2.


Delivering non-communicable disease services through primary health care in selected south Asian countries: are health systems prepared?.

Ahmed S, Krishnan A, Karim O, Shafique K, Naher N, Srishti S Lancet Glob Health. 2024; 12(10):e1706-e1719.

PMID: 39178879 PMC: 11413526. DOI: 10.1016/S2214-109X(24)00118-9.


The Prevalence and Epidemiological Features of Ischaemic Heart Disease in Sri Lanka.

Wijemunige N, Rannan-Eliya R, Herath H, ODonnell O Glob Heart. 2024; 19(1):49.

PMID: 38854432 PMC: 11160409. DOI: 10.5334/gh.1330.


Gaps in asthma diagnosis and treatment in low- and middle-income countries.

Barne M Front Allergy. 2023; 4:1240259.

PMID: 37937199 PMC: 10627233. DOI: 10.3389/falgy.2023.1240259.


References
1.
Balasubramaniam R, Beneragama B, Sri Ranganathan S . A national survey of availability of key essential medicines for children in Sri Lanka. Ceylon Med J. 2011; 56(3):101-7. DOI: 10.4038/cmj.v56i3.3597. View

2.
Mendis S, Fukino K, Cameron A, Laing R, Filipe Jr A, Khatib O . The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007; 85(4):279-88. PMC: 2636320. DOI: 10.2471/blt.06.033647. View

3.
Senarathna S, Mannapperuma U, Fernandopulle B . Medicine prices, availability and affordability in Sri Lanka. Indian J Pharmacol. 2011; 43(1):60-3. PMC: 3062124. DOI: 10.4103/0253-7613.75672. View

4.
van Mourik M, Cameron A, Ewen M, Laing R . Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010; 10:25. PMC: 2898673. DOI: 10.1186/1471-2261-10-25. View

5.
Hogerzeil H, Liberman J, Wirtz V, Kishore S, Selvaraj S, Kiddell-Monroe R . Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013; 381(9867):680-9. DOI: 10.1016/S0140-6736(12)62128-X. View